Therapeutic Asset Ratings
1,550 results matching 1 filter
129,439 assets · 8,701 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Solvazinc
Botulinum Toxin
Cairo University
Early P1
C
(39)
Solvazinc
Myofascial Pain Syndrome
Cairo University
Early P1
C
(39)
sph5030
Metastatic Neoplasm
Shanghai Pharmaceuticals Holding Co., Ltd
Early P1
C
(39)
SUXAMETHONIUM CHLORIDE
ECT
Min Su
Early P1
C
(39)
SUXAMETHONIUM CHLORIDE
Esketamine
Min Su
Early P1
C
(39)
Sxrn
Cachexia
Jiangsu Nutai Biologics Co., Ltd
Early P1
C
(39)
SYNTHETIC LEVOTHYROXINE
Avolition
Peking University
Early P1
C
(39)
SYNTHETIC LEVOTHYROXINE
Hepatic Steato-Fibrosis
Post Graduate Institute of Medical Education and Research, Chandigarh
Early P1
C
(39)
sz011 car-nk
Ovarian Carcinoma
Shantou University Medical College
Early P1
C
(39)
sz011 car-nk
Triple-Negative Breast Carcinoma
First Affiliated Hospital of Shantou University Medical College
Early P1
C
(39)
TAMOXIFEN
ESR1 Gene Mutation
University of Wisconsin, Madison
Early P1
C
(39)
Targeted Aml1-Eto Neoantigen Cytotoxic T Cells
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
BGI, China
Early P1
C
(39)
Targeted Aml1-Eto Neoantigen Cytotoxic T Cells
Neoantigen
BGI, China
Early P1
C
(39)
Tart Cherry
Joint Pain
Philip Chang
Early P1
C
(39)
Tc-D101 Car-T
CAR-T Cell Therapy
TCRCure Biopharma Ltd.
Early P1
C
(39)
Tc-D101 Car-T
Small Cell Lung Carcinoma
TCRCure Biopharma Ltd.
Early P1
C
(39)
T Cell Targeting Flt3 Chimeric Antigen Receptor
FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early P1
C
(39)
Tc-G203 Cells Treatment
Hepatocellular Carcinoma
Beijing GoBroad Hospital
Early P1
C
(39)
TECHNETIUM TC 99M SESTAMIBI
Estrogen-Receptor Negative Breast Cancer
M.D. Anderson Cancer Center
Early P1
C
(39)
TECHNETIUM TC 99M SESTAMIBI
Her2-Receptor Negative Breast Cancer
M.D. Anderson Cancer Center
Early P1
C
(39)
TECHNETIUM TC 99M SESTAMIBI
Progesterone-Receptor Negative Breast Cancer
M.D. Anderson Cancer Center
Early P1
C
(39)
TECHNETIUM TC 99M SESTAMIBI
Triple-Negative Breast Carcinoma
M.D. Anderson Cancer Center
Early P1
C
(39)
TEONANACATL
Fibromyalgia
Maastricht University
Early P1
C
(39)
Terazosin
Adenosine Triphosphate Activities
University of Iowa
Early P1
C
(39)
TIL
Adult Glioblastoma
Hebei Senlang Biotechnology Inc., Ltd.
Early P1
C
(39)
Showing 776 to 800 of 1,550 assets
Previous
Page 32 of 62
Next